How to Cite
Abstract
Smoking not only increases the risk of the development of malignant tumors (MT), but affects the disease prognosis, mortality and survivability of cancer patients. The link between the smoking of cancer patients and increased risk of death by all diseases and oncological causes has been established. Mortality increases with the growth of the smoking intensity, i.e. the number of cigarettes, smoked per day. Smoking is associated with the worst general and oncological survivability. The statistically trend-line between the smoking intensity and survivability was observed: each additional unit of cigarette consumption (pack/year) leads to the Overall Survival Reduction by 1% (p = 0.002). The link between smoking and the risk of developing second primary tumors has been confirmed. Smoking increases the likelihood of side effects of the antitumor therapy both drug therapy and radiation therapy and reduces the treatment efficacy. The smoking cessation leads to a significant improvement in the prognosis of a cancer patient. Scientific data on the negative effect of smoking on the prognosis of cancer patients have a major clinical importance. The treatment program for cancer patients should include science-based methods for the smoking cessation. The latter is fundamentally important, taking into account that the smoking frequency among cancer patients is much higher than in the population.References
Состояние онкологической помощи населению России в 2016 году. / Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой - Москва.: МНИОИ им. П.А. Герцена - филиал ФГБУ «НМИРЦ» Минздрава России, 2017. - С. 236.
Abdel-Rahman О., Cheung W.Y Impact of smoking history on the outcomes of women with early-stage breast cancer: a secondary analysis of a randomized study // Med. Oncol. - 2018. - Vol. 35(5). - P 1-7.
Alberg A.J., Shopland D.R., Cummings K.M. The 2014 Surgeon General's Report: Commemorating the 50th Anniversary of the 1964 Report of the Advisory Committee to the US Surgeon General and Updating the Evidence on the Health Consequences of Cigarette Smoking // American Journal of Epidemiology. - 2014. - Vol. 179 (4). - P. 403-412.
Baker S.R. Risk factors in multiple carcinomas of the lip // Otolaryngol. Head. Neck. Surg. (1979). - 1980. - Vol. 88(3). - P 248-251.
Chang S.L., Lo C.H., Peng H.L. et al. Factors associated with continued smoking after treatment of oral cavity cancer: An age and survival time-matched study // J. Adv. Nurs. - 2018. - Vol. 74(4). - P 926-934.
De Nunzio C., Andriole G.L., Thompson I.M. Jr., Freedland S.J. Smoking and Prostate Cancer: A Systematic Review // Eur. Urol. Focus. - 2015. -Vol. 1(1). - P. 28-38.
Dresler C.M. Is it more important to quit smoking than which chemotherapy is used? // Lung Cancer. - 2003. -Vol. 39(2). - P 119-124.
Ehdaie B., Furberg H., Zabor E.C. et al. Impact of smoking status at diagnosis on disease recurrence and death in upper tract urothelial carcinoma // BJU Int. - 2013. - Vol. 111(4). - P 589-595.
Ehrenzeller MF., Mayer DK., Goldstein A. Smoking Prevalen ce and Management Among Cancer Survivors // Oncol. Nurs. Forum. - 2018. - Vol. 45(1). - P 55-68.
Fajkovic H., Shariat SF., Klatte T. et al. Impact of smoking status on survival after cy-toreductive nephrectomy for metastatic renal cell carcinoma // World J. Urol. - 2016. - Vol. 34(10). - P 1411-1419.
Fankhauser C.D., Mostafid H. Prevention of bladder cancer incidence and recurrence: nutrition and lifestyle // Curr. Opin. Urol. - 2018. - Vol. 28(1). - P 88-92.
Ferketich AK., Niland JC., Mamet R. et al. Smoking status and survival in the national comprehensive Cancer network non-small cell lung Cancer cohort // Cancer. -2013. -Vol. 119(4). - P. 847-53.
Foerster B., Pozo C., Abufaraj M. et al. Association of Smoking Status With Recurrence, Metastasis, and Mortality Among Patients With Localized Prostate Cancer Undergoing Prostatectomy or Radiotherapy: A Systematic Review and Meta-analysis // JAMA Oncol. - 2018. - Vol. 4(7). - P. 953-961.
Hanna N., Mulshine J., Wollins DS. et al. Tobacco cessation and control a decade later: American society of clinical oncology policy statement up-date // J. Clin. Oncol. - 2013. -Vol. 31. - P. 3147-3157.
IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans // A Review of Human Carcinogens. Part E: Personal Habits and Indoor Combustions. - Vol. 100E. - Lyon, France: IARC Press; 2012.
Japuntich S.J., Kumar P, Pendergast J. et al. Smoking status and survival among a national cohort of lung and colorectal cancer patients // Nicotine Tob. Res. - 2018. - P. 1-28.
Johnston-Early A., Cohen M.H., Minna J.D. et al. Smoking abstinence and small cell lung cancer survival. An association // JAMA. - 1980. - Vol. 244(19). - P 21752179.
Kaiser E.G., Prochaska J.J., Kendra M.S. Tobacco Cessation in Oncology Care // Oncology. - 2018. - Vol. 95(3). - P 129-137.
Kim H., Kim M.H., Park YS. et al. Factors That Predict Persistent Smoking of Cancer Survivors // J. Korean Med Sci. - 2015. - Vol. 30(7). - P 853-859.
Kwan M.L., Garren B., Nielsen M.E., Tang L. Lifestyle and nutritional modifiable factors in the prevention and treatment of bladder cancer // Urol. Oncol. - 2018. - P 1-7.
Latimer K.M. Lung Cancer: Smoking Cessation // FP Essent. - 2018. - Vol. 464. - P. 11-16.
Mari A., Abufaraj M., Foerster B. et al. Oncologic Effect of Cumulative Smoking Exposure in Patients Treated With Salvage Radical Prostatectomy for Radiation-recurrent Prostate Cancer // Clin. Genitourin. Cancer. - 2018 - Vol. 16(3). - P. 1-9.
Mota P, Sousa PM., Botelho F. et al. Smoking Cessation after Bladder Cancer Diagnosis // Acta. Med. Port. -2018. - Vol. 31(2). - P 101-108.
O'Malley M., King A.N., Conte M. et al. Effects of cigarette smoking on metabolism and effectiveness of systemic therapy for lung cancer // J. Thorac. Oncol. - 2014. -Vol. 9(7). - P. 917-926.
Ord ez-Mena J.M., Walter V., Schttker B. et al. Impact of prediagnostic smoking and smoking cessation on colorectal cancer prognosis: a meta-analysis of individual patient data from cohorts within the CHANCES consortium // Ann Oncol. - 2018. - Vol. 29(2). - P 472-483.
Osazuwa-Peters N., Adjei Boakye E., Chen B.Y et al. Association Between Head and Neck Squamous Cell Carcinoma Survival, Smoking at Diagnosis, and Marital Status // JAMA Otolaryngol. Head Neck Surg. - 2017. - P. 43-50.
Platek A.J., Jayaprakash V., Merzianu M. et al. Smoking cessation is associated with improved survival in oropharynx cancer treated by chemoradiation // Laryngoscope. - 2016. - Vol. 126(12). - P 2733-2738.
Sharp L., McDevitt J., Carsin A.E. et al. Smoking at diagnosis is an independent prognostic factor for cancer-specific survival in head and neck cancer: findings from a large, population-based study // Cancer Epidemiol Biomarkers Prev. - 2014. - Vol. 23(11). - P. 2579-2590.
Shields PG. New NCCN Guidelines: Smoking Cessation for Patients With Cancer // J. Natl. Compr. Canc. Netw. - 2015. - Vol. 13. - P 643-645.
Shiels M.S., Gibson T., Sampson J. et al. Cigarette smoking prior to first cancer and risk of second smoking-associated cancers among survivors of bladder, kidney, head and neck, and stage I lung cancers // J. Clin. Oncol. - 2014. - Vol. 32(35). - P 3989-3995.
Sterba K.R., Garrett-Mayer E., Carpenter M.J. et al. Smoking status and symptom burden in surgical head and neck cancer patients // Laryngoscope. - 2017. - Vol. 127(1). - P. 127-133.
Surgeon General Report on Smoking and Health: 50-years of Progress/ https://www.surgeongeneral.gov/library/ reports/50-years-of-progress/full-report.pdf.
Toll B.A., Brandon T.H., Gritz E.R. et al. Assessing tobacco use by cancer patients and facilitating cessation: an American Association for Cancer Research policy statement // Clin. Cancer Res. - 2013. - Vol. 19. - P 1941-1948.
Wang Z., McLoone P, Morrison D.S. Diet, exercise, obesity, smoking and alcohol consumption in cancer survivors and the general population: a comparative study of 16 282 individuals // Br. J. Cancer. - 2015. -Vol. 112(3). - P. 572-575.
Warren G.W., Sobus S., Gritz E.R. The biological and clinical effects of smoking by patients with cancer and strategies to implement evidence-based tobacco cessation support // Lancet Oncol. - 2014. - Vol. 15(12). - P 1-23.
World Health Organization. WHO global report on trends in prevalence of tobacco smoking 2000-2025, first edition. Geneva: World Health Organization.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© АННМО «Вопросы онкологии», Copyright (c) 2019